Related by context. All words. (Click for frequent words.) 70 K ras mutations 68 FUSILEV enhances 67 Umbilical cord stem cells 67 CYT# potent vascular disrupting 66 kidney urologic 66 Ribavirin causes 66 unresectable tumors 66 Gleevec resistant 65 T#I [002] 65 hypereosinophilic syndrome 65 Systemic lupus erythematosus 65 systemic amyloidosis 65 CYP#A# CYP#D# 65 included exfoliative dermatitis 65 recurrent glioblastoma multiforme 64 chronic eosinophilic leukemia 64 myelofibrosis polycythemia vera 64 Known hypersensitivity 64 haematologic 64 vinca alkaloid 64 Leukemias 64 anaphylactic reactions bronchospasm 64 neovascular diseases 63 cystic fibrosis chronic pancreatitis 63 Liprotamase 63 hyperphenylalaninemia HPA due 63 allogeneic HSCT 63 Non inferiority 63 Vidaza ® 63 Ph + acute lymphoblastic 63 infectious diseases autoimmune diseases 63 Glucocorticoids 63 dyslipidemia abnormal 63 IMiDs ® 63 Gamunex C 63 glutamic acid decarboxylase 63 Systemic lupus erythematosus SLE 63 NAGS deficiency 63 HER2 expression 63 insulin secreting beta 63 abnormal clotting 63 erythema nodosum 63 Protein Kinase C 63 Sezary syndrome 63 Chronic pancreatitis 63 Warfarin Coumadin 63 lymphomas leukemias 63 CYP#A# substrate 63 hypervascular tumors 63 myelodysplastic myeloproliferative diseases 63 autoinflammatory diseases 63 R Saizen R 63 transfusion syndrome 63 humanized therapeutic 63 endosomal release 63 chronic granulomatous disease 63 receiving XGEVA 62 Mg Usa 62 Carcinoid tumors 62 Clostridium Difficile Associated 62 erlotinib Tarceva ® 62 GRNOPC1 contains 62 allogeneic transplants 62 Basal Cell 62 renal failure interstitial lung 62 TTR amyloidosis 62 chronic myeloid 62 rheumatoid arthritis lupus 62 Acute myeloid leukemia 62 Factor Receptor 62 delta gamma agonist 62 abnormal p# 62 relapsed MM 62 decompensated liver disease 62 #beta HSD1 62 systemic corticosteroid 62 HLA DR4 immune 62 antiplatelet medications 62 dyskeratosis congenita 62 Valproic acid 62 oral prodrug 62 castration resistant hormone refractory 62 Candida infection 62 BRAF gene mutations 62 Nilotinib 62 Cathepsin B 62 endocrine therapies 62 Atopic eczema 62 receptor inhibitor 62 vWD 62 cause cardiac channelopathies 62 lichen planus 62 thalidomide Thalomid 62 intravenous bisphosphonates 62 systemic autoimmune 62 CYP#A# isoenzyme 62 subependymal giant cell 62 histone deacetylases 62 BCG refractory carcinoma 62 glucocerebroside primarily 62 pancreatic prostate 62 5 HT2A serotonin 62 novel VDA molecule 62 mycosis fungoides 62 Adjuvant chemotherapy 62 p# biomarker 62 galiximab 62 folinic acid 62 gefitinib Iressa 62 chemoresistant 61 Vorinostat 61 Von Willebrand disease 61 hematopoietic cell 61 Intravenous immunoglobulin 61 TNF Tumor Necrosis Factor 61 treating sarcoma testicular 61 demonstrated antitumor activity 61 deCODE ProstateCancer TM 61 ANCA associated 61 Glioblastoma multiforme GBM 61 Surgical resection 61 multiple sclerosis psoriasis 61 virally induced 61 psoriasis vulgaris 61 huntingtin gene 61 induced mucositis 61 metastatic lymph nodes 61 primary immunodeficiency PI 61 Benign tumors 61 tetracycline antibiotic 61 GSTT1 61 Celiac sprue 61 Pernicious anemia 61 radiolabeled TM# 61 transthyretin amyloidosis 61 Polyneuropathy 61 muscular dystrophy cystic fibrosis 61 transthyretin TTR 61 melanocyte stimulating hormone 61 PLX STROKE targeting 61 Lupus nephritis 61 interferon alpha IFN 61 ovarian endometrial 61 KRAS mutation 61 HBeAg negative 61 anemia thrombocytopenia 61 inhibitor COX 61 fusion enhancers 61 blood clotting protein 61 leiomyomas 61 fibrate drugs 61 diabetic kidney 61 psoriasis rheumatoid arthritis 61 OnDose TM 61 Kuvan sapropterin dihydrochloride 61 beta islets 61 investigational monoclonal antibody 61 leukemia multiple myeloma 61 intestinal polyps 61 Orally administered 61 Menopausal hormone therapy 61 nutlin 3a 61 bendamustine ifosfamide 61 Lichen planus 61 hematological parameters 61 Interferon beta 61 treating neuropathic pain 61 Estrogen Receptor 61 non polyposis colorectal 61 interleukin IL -# 61 refractory chronic lymphocytic 61 imatinib Gleevec 61 hematopoietic cancers 61 certain protein tyrosine 61 cisplatin resistant 61 MET amplification 61 synovial cells 61 VEGF inhibitors 61 Epstein Barr Virus EBV 61 benign prostatic hypertrophy BPH 61 Carbamazepine 61 allogeneic hematopoietic cell 60 5 FU leucovorin 60 serum phosphorous 60 RNAi therapeutic targeting 60 Letairis ambrisentan 60 chemokine receptor 60 Nonalcoholic fatty liver 60 radiation chemoradiation 60 cardio metabolic diseases 60 HER2 positivity 60 TNF blocker therapy 60 HER2 overexpression 60 malignant ovarian 60 immune modulating 60 DNA methylation patterns 60 Navelbine 60 Peginterferon alfa 2b 60 RhuDex R 60 ADPKD 60 SSc 60 Crizotinib 60 severe malignant osteopetrosis 60 urinary bladder wall 60 5 HT6 receptor 60 inhibits blood clotting 60 CTAP# 60 Vidofludimus 60 Relapsing remitting MS 60 Nonsteroidal anti inflammatory 60 androgen receptor AR 60 anti amnesic 60 autoimmune uveitis 60 molecular abnormalities 60 pathophysiological effects 60 trastuzumab Herceptin R 60 Naive Patients 60 headache abdominal pain 60 ADVEXIN therapy 60 neuroinflammatory 60 gamma globin gene 60 leiomyoma 60 small molecule Hedgehog 60 Scorpion venom 60 immunosuppressive therapies 60 pulmonary hypertension PH 60 treat chronic sinusitis 60 Sapacitabine 60 ATRA IV 60 PNP inhibitor 60 BEXXAR Therapeutic Regimen 60 inherited metabolic diseases 60 NorStates Bank serves 60 genetic lysosomal storage 60 selective modulator 60 severe hypersensitivity reactions 60 mutated K ras 60 secondary amenorrhea 60 SMN1 60 ZOLINZA 60 calcineurin inhibitors 60 antibody IgE 60 Levaquin levofloxacin 60 Neurofibromatosis type 60 progressive neurodegenerative 60 pathological hallmark 60 bladder ovarian 60 papillary renal cell carcinoma 60 immunocompetent adults 60 metaplasia 60 post herpetic 60 immune globulins 60 thymidylate synthase 60 underlying vasculopathy 60 chimeric monoclonal antibody 60 anthracycline induced 60 Dasatinib 60 HLA DR2 60 SOD2 gene 60 complement inhibitor eculizumab 60 orchitis 60 relapsed leukemia 60 thymic carcinoma 60 essential thrombocythemia ET 60 ZACTIMA TM ZD# 60 inhibitor PPI 60 inhibit oxidative stress 60 NR2B selective 60 imatinib Gleevec ® 60 anthracycline chemotherapy 60 Epidermal Growth Factor Receptor 60 factor HGF 60 substantially excreted 60 pancreatic endocrine 60 Papillary 60 non porcine pancreatic 59 psoriatic arthritis PsA 59 systemic juvenile idiopathic 59 Chronic lymphocytic leukemia 59 leukemia lymphoma multiple myeloma 59 Pegloticase 59 SGPT 59 pregnancy bacterial vaginosis 59 Bisphosphonate 59 Malignant mesothelioma 59 Clusterin 59 homozygous familial hypercholesterolemia 59 idiopathic thrombocytopenic purpura ITP 59 bronchial hyperresponsiveness 59 HIV HCV coinfected 59 MKC# MT 59 bexarotene 59 AGTR1 59 alkylating agent 59 diagnostic biomarker 59 LRP5 59 stratifying patients 59 Glucocorticoid 59 5 fluorouracil leucovorin 59 antiproliferative effects 59 Oracea TM 59 malignant pleural mesothelioma 59 FGFR4 59 neuropathic pain metabolic diseases 59 tryptase 59 recombinant PSMA vaccine 59 Mesenchymal 59 Anthracycline 59 immunotoxin 59 Low density lipoprotein 59 irinotecan doxorubicin oxaliplatin paclitaxel 59 containing abacavir 59 tigecycline 59 cytolytic 59 soluble tumor necrosis 59 D aspartate NMDA receptor 59 acetonide FA 59 MEK ERK 59 hamartomas 59 circulating endothelial cells 59 mTOR mammalian target 59 LAB CGRP 59 Teriflunomide 59 Angiotensin II 59 commercialize deforolimus 59 Squamous Cell 59 Paraplatin ® carboplatin 59 proteoglycan 59 dermatologic reactions 59 Detrol Detrol LA 59 Azacitidine 59 neovasculature 59 deCODE AF TM 59 haematopoietic 59 Malignant Glioma 59 LHRH receptor positive 59 OGG1 59 flavopiridol 59 factor Xa 59 receiving VELCADE 59 selective serotonin 2C receptor 59 IGFBP 3 59 optimized siRNA 59 castrate resistant prostate cancer 59 neovascularisation 59 antifungal medications 59 anti inflammatory cytokine 59 vaginal candidiasis 59 hypermethylated 59 Haptoglobin 59 EGFR inhibitors 59 demonstrated anti amnesic 59 DNA methyltransferases 59 thromboxane A2 59 Cojocaru correspondent 59 bullous 59 thyroid deficiency 59 intracranial atherosclerosis 59 doxorubicin Adriamycin 59 VOID IN 59 PLX MS 59 erythematosus 59 dasatinib Sprycel 59 Chronic lymphocytic leukemia CLL 59 non mutated KRAS 59 imatinib resistant 59 mixed hyperlipidemia 59 breast endometrial 59 PAR1 59 GISTs 59 adalimumab Humira 59 Plaquenil 59 leukemia AML 59 myeloproliferative neoplasms MPNs 59 hypercholesterolaemia 59 inhaled bronchodilators 59 metaglidasen 59 deCODE BreastCancer 59 Pemphigus 59 JAK2 enzyme 59 musculoskeletal metabolic 59 CD#c 59 EEG abnormalities 59 metastatic renal 59 benign neoplasms 59 Fingolimod 59 C1 INH deficiency 59 Hereditary angioedema HAE 59 atypical hemolytic uremic syndrome 59 CYT# QbG# 59 survival motor neuron 59 Genetic variations 59 ADAMTS# 59 ULTRAM ER 59 selectively inhibited 59 Pechanga Theater 59 von Hippel Lindau 59 interleukin IL -6 59 peptide antigens 59 Levels Linked 59 Platelet Derived Growth 59 vWF 59 teratogens 59 liposomal amphotericin B 59 melanoma ovarian 59 KRAS mutations 59 autosomal recessive disorder 59 HIV coinfected 59 Elotuzumab 59 Acute myelogenous leukemia 59 eTag assays 59 acute humoral rejection 59 MAGE A3 ASCI 59 radioiodine therapy 59 conventional DMARDs 59 Pemetrexed 59 Antitumor Activity 59 hepatoma 59 p# activation 59 precancerous condition 59 ribonucleotide reductase clinically validated 59 AA Amyloidosis 59 MTP inhibitor 59 CFTR cystic fibrosis transmembrane 59 Cytotoxic T 59 autosomal dominant polycystic kidney 59 HIF 1a 59 myopathies 59 renal tubular 59 potent inducer 59 Muraglitazar 59 monogenic 59 hepatocellular carcinomas 59 NS5B polymerase 59 metastatic colorectal 59 Hyperlipidemia 59 bone marrow lymph nodes 59 5 HT1A receptor 59 paraneoplastic 59 genotoxic stress 59 inherited retinal degeneration 59 Cytarabine 59 immunologic diseases 59 Spinal Fluid 59 orally bioavailable mimics 59 histone deacetylase HDAC 59 chronic thromboembolic pulmonary 59 gastrointestinal stromal tumors GISTs 59 Photodynamic therapy PDT 58 alkylating 58 Li Fraumeni 58 myeloproliferative neoplasms 58 selective inverse agonist 58 cervical lymph nodes 58 tensin homolog 58 indolent follicular non 58 RAS MAPK pathway 58 Malignant glioma 58 Atypical Hemolytic Uremic Syndrome 58 histologic subtype 58 inherited metabolic disorders 58 Methylnaltrexone 58 basal cell nevus syndrome 58 MIF gene 58 VKORC1 58 Primary Hypercholesterolemia 58 essential thrombocythemia 58 alpha1 antitrypsin deficiency 58 inflammatory PDE 58 lactate dehydrogenase 58 lymphoma myeloma 58 neuroendocrine cancers 58 lupus multiple sclerosis 58 acute porphyria 58 MetroGel 58 humanised monoclonal antibody 58 anti CD3 antibody 58 gastrointestinal stromal tumors GIST 58 target enzyme thymidylate 58 Polycystic ovary syndrome 58 blood coagulation disorders 58 Flu Cy 58 Omacetaxine 58 TNF Blockers 58 either acutely decompensated 58 pan histone deacetylase 58 Mild hypothermia 58 immunomodulatory properties 58 alkylating agents 58 identify protein biomarkers 58 renal cell carcinomas 58 TTR gene 58 primary hyperparathyroidism 58 inflammatory demyelinating 58 cardiotoxic 58 ACTEMRA TM 58 pancreatic lung 58 tumors GIST 58 Shows Promise Against 58 Metastatic breast cancer 58 ELISPOT assay 58 Dupuytren Disease 58 Nevada Casino Aztar 58 IAP inhibitor 58 Severe Primary IGFD 58 Hutchinson Gilford progeria 58 Parnate 58 colorectal carcinoma 58 BRAF gene 58 immune modulator 58 Autoantibodies 58 refractory Hodgkin 58 somatostatin analogues 58 immunomodulation 58 alpha interferons 58 uterus fallopian tubes 58 minimally symptomatic 58 myeloproliferative diseases 58 urinary N telopeptide 58 carcinoid tumor 58 cisplatin gemcitabine 58 naturally occurring amino acid 58 intradermal injection 58 exocrine 58 cell carcinoma RCC 58 immunocompetent 58 endogenous ligands 58 dopamine receptor agonist 58 thiazolidinedione TZD 58 pamidronate 58 triggers apoptosis programmed 58 APOL1 58 barbiturates benzodiazepines 58 inducible nitric oxide synthase 58 Treg cell 58 accumulate preferentially 58 severe hepatic dysfunction 58 LHRH antagonists 58 CINQUIL 58 γ secretase 58 syngeneic 58 clonogenic 58 hematologic disorders 58 polycystic ovarian disease 58 Hurthle cell 58 embryonal rhabdomyosarcoma 58 nAChRs 58 TTF Therapy 58 molecular biomarkers 58 Idiopathic pulmonary fibrosis IPF 58 haematopoietic stem cell 58 nonalcoholic steatohepatitis 58 Ankylosing spondylitis 58 metastatic androgen independent 58 cTnI 58 G6PD deficiency 58 TRAIL induced apoptosis 58 CYP #D# 58 p# Shc 58 Anthracyclines 58 relapsing remitting MS RRMS 58 itraconazole Sporanox 58 EGFR tyrosine kinase inhibitors 58 immunodeficient 58 extramedullary 58 dominantly inherited 58 differentiated thyroid 58 Cryptococcus neoformans 58 Cariprazine 58 achieved CCyR 58 metastatic gastric 58 % Caprylate Chromatography 58 BRAF V#E 58 signal transduction inhibitors 58 lupus scleroderma 58 Chlamydia psittaci 58 Viral infections 58 busulfan 58 gastric carcinoma 58 immunomodulating 58 systemic mastocytosis 58 Related Anemia 58 J Am Coll 58 paroxetine Paxil 58 uterine fibroids endometriosis 58 hepatic liver 58 bacterium Mycobacterium tuberculosis 58 HMG CoA reductase inhibitors 58 leukocyte adhesion 58 M2 subunit 58 nimodipine 58 Pertuzumab 58 anti angiogenic agent 58 ifosfamide standard 58 carcinoembryonic antigen 58 induce orthostatic hypotension 58 BCR ABL protein 58 superficial bladder cancer 58 Acute myeloid leukemia AML 58 experimental autoimmune encephalomyelitis 58 Diabetic neuropathy 58 neurotrophic 58 autoantibody levels 58 chronic lyme 58 non ulcer dyspepsia 58 Genetic mutations 58 small molecule tyrosine 58 ischemic diseases 58 serum aminotransferase levels 58 Myelodysplastic syndromes 58 uric acid lowering 58 INVEGA ® 58 B7 H3 58 Upregulation 58 treating sarcoma lymphoma 58 Hypertrophy 58 Menstrual blood 58 calcitonin gene related 58 Cysts 58 Sjögren syndrome 58 immuno modulatory 58 Renal Impairment 58 histone deacetylase inhibitor 58 Janus kinase 58 Aldosterone 58 Th1 type 58 Tumor Necrosis Factor 58 humanised antibody designed 58 OHR/AVR# 58 Enlarged prostate 58 SGS# 58 chronic immune thrombocytopenic 58 palliative radiotherapy 58 hemorrhagic cystitis 58 Basal cell 58 Factor XIII 58 mineralocorticoid 58 Etanercept 58 biologic antibody 58 MCSP respectively 58 Ectopic pregnancy 58 intravenous immunoglobulin IVIg 58 sarcomatoid 58 aplastic anemia AA 58 Gastrointestinal Stromal Tumors 58 beta sitosterol 58 hypercalcemia 58 KRAS oncogene 58 mastocytosis 58 diabetic retinopathy DR 58 anaplastic lymphoma kinase 58 lysosomal storage disease 58 clomipramine 58 Shark cartilage 58 candidemia 58 SomatoKine 58 erythematosus SLE 58 Nicotinamide 58 Peritoneal mesothelioma 58 thyroglobulin 58 mucinous 58 refractory metastatic 58 antiangiogenic therapy 58 inflammatory autoimmune diseases 58 Lewy bodies DLB 58 pancreatic adenocarcinoma 58 Aviptadil 57 Hypoxia Inducible Factor 57 protein tyrosine phosphatase 1B 57 UNCERTAINTIES OR OTHER FACTORS 57 Irritable bowel syndrome IBS 57 Zollinger Ellison Syndrome 57 fibrotic disease 57 pharmacologic agents 57 SIADH 57 Campath alemtuzumab 57 neoplastic cells 57 immunomodulators 57 Romiplostim 57 NOMID 57 5 Fluorouracil 57 Oral corticosteroids 57 Prognostic factors 57 bronchoalveolar lavage BAL 57 ® lenalidomide 57 adrenocortical cancer 57 metastatic bladder 57 metastatic malignant 57 node metastases 57 pleiotropic 57 apoptosis induced 57 hematological diseases 57 TMP SMX 57 infliximab monotherapy 57 Diomed EVLT R 57 gastrointestinal stromal tumor 57 Decitabine 57 cranial irradiation 57 Corticosteroids 57 CYP #A# 57 adrenal suppression 57 ErbB2 positive 57 gastrointestinal stromal 57 Cholinesterase Inhibitors 57 neuro inflammatory 57 receptor tyrosine kinase inhibitor 57 overactivated 57 IV bisphosphonates 57 ABCB1 57 Bronchiectasis 57 elevated uric acid 57 Slows Progression 57 antimetabolites 57 tests miRview ™ 57 gastrointestinal stromal tumors 57 hormonally sensitive 57 TNF alpha antagonist 57 histone deacetylase 57 Opportunistic infections 57 Prostate specific antigen 57 OMP #R# 57 delay bone metastases 57 antiphospholipid syndrome 57 Gel repository corticotropin injection 57 enzyme inhibitor 57 hyperparathyroidism 57 underwent surgical resection 57 Ischemic 57 anti angiogenic agents 57 significant cytopenia eg 57 Telik logo TELINTRA 57 superficial basal cell carcinoma 57 arterial calcification 57 endocrine tumors 57 mTOR inhibitors 57 pancreatic colon 57 pretransplant 57 severe congenital neutropenia 57 investigational oral inhibitor 57 PI3K Akt 57 genus Plasmodium 57 Benign breast 57 STRIKE PRICE COMPARES TO 57 BYETTA exenatide injection 57 refractory acute myeloid 57 localized renal 57 azelaic acid 57 cutaneous lupus 57 EGFRIs 57 Vincristine 57 hypokalemia hypomagnesemia 57 Navelbine R 57 inflammatory bowel syndrome 57 PROCRIT ® 57 mGluR5 antagonist 57 siRNA knockdown 57 interstitial cystitis IC 57 bleomycin 57 bone marrow suppression 57 chemo resistant 57 Squamous Cell Carcinoma 57 Cystatin C 57 tumor necrosis 57 CCR9 antagonist 57 Multipotent 57 basal cell carcinoma BCC 57 torsade de pointes 57 liver metastasis 57 autoimmune thyroid 57 Darinaparsin 57 proton MR spectroscopy 57 diaper dermatitis 57 Kinoid 57 peritoneal carcinomatosis 57 delivered RNAi therapeutic 57 TGF b 57 HUMIRA resembles 57 skeletal metastases 57 ceroid lipofuscinosis NCL 57 inverse agonist 57 hyaluronidase enzyme 57 relapsed ALL 57 TLR9 agonists 57 epithelial tumors 57 colorectal adenocarcinoma 57 Immunoglobulin E 57 Vidaza azacitidine 57 Heavy menstrual bleeding 57 chronic periodontitis 57 postoperative ileus 57 Lenocta TM sodium stibogluconate 57 Dr. Bezprozvanny 57 lactate dehydrogenase LDH 57 malignant ascites 57 antibody mediated 57 IL 1ß 57 selective inhibition 57 inherited neurodegenerative 57 targeting PCSK9 57 Stargardt Macular Dystrophy SMD 57 oral thrush 57 deletion 5q 57 NMP# protein 57 diarrhea predominant irritable 57 anti CD3 57 biliary tract cancer 57 SinuNase TM 57 hypothalamic pituitary 57 alanine aminotransferase 57 osteoprotegerin 57 penicillin resistant Streptococcus 57 BoNTA 57 synthetic retinoid 57 Bone marrow transplant 57 transgenic rats 57 Escanaba Farmington Hills 57 Alkaline Phosphatase 57 mitochondrial mutations 57 ocular inflammatory 57 chronic idiopathic thrombocytopenic purpura 57 neurologically stabilized 57 hereditary predisposition 57 BRAF kinase 57 triple nucleoside regimen 57 Gemzar gemcitabine 57 basal cell carcinoma squamous 57 chemotherapy cisplatin 57 Thalomid ® 57 glial derived neurotrophic 57 bronchoalveolar lavage fluid 57 relapsed SCLC 57 Lung transplantation 57 Hepatocytes 57 ganciclovir 57 MGd 57 Autoimmune hepatitis 57 autoimmune encephalitis 57 recurrent genital herpes 57 riociguat 57 Cytogenetic 57 Hyperkalemia 57 anthracyclines taxanes 57 urothelial cancer 57 Pulmonary hypertension 57 6 mercaptopurine 57 underlying pathophysiology 57 CCR5 delta# 57 Anidulafungin 57 NMIBC 57 Macular edema 57 HER2 HER2 57 metastatic GIST 57 ergot alkaloids 57 Phase 2b Clinical Trial 57 polycythemia vera PV 57 thymectomy 57 proteins peptides 57 PDE# 57 hypercalcaemia 57 soluble CD# ligand 57 1 diabetes T1D 57 endometrial hyperplasia 57 diabetic gastroparesis 57 GATA3 57 epiglottitis 57 mecasermin 57 T1DM 57 underwent prostate biopsy 57 intra arterial chemotherapy 57 antiestrogen 57 Bucindolol Based 57 autoantibody positive 57 suppress viral replication 57 p# deficient 57 Th2 cytokines 57 Diabetic macular edema 57 intact parathyroid hormone 57 malignant prostate 57 Thyroid disorders 57 steroidogenic 57 sorafenib Nexavar 57 INSPIRE Trial Phase III 57 LHON 57 osteoprotegerin OPG 57 secondary hyperparathyroidism 57 prostate carcinoma 57 prednisone prednisolone plus 57 epithelial ovarian 57 NUCYNTA ™ 57 osteolytic bone disease 57 immunological reaction 57 Aggrastat ® tirofiban hydrochloride 57 Velcade bortezomib 57 inactivating mutations 57 lysosomal enzyme 57 recurrent acute pancreatitis 57 SETDB1 57 pre malignant lesions 57 Diabetic nephropathy 57 medically inoperable 57 Pseudomonas aeruginosa infections 57 thrombocytopenia neutropenia 57 nonsteroidal antiinflammatory drugs 57 Myelodysplastic Syndrome 57 cardiovascular restenosis cancer 57 oligodendrogliomas 57 erlotinib Tarceva 57 microglial activation 57 Lymphoid 57 Navelbine ® 57 fluoroquinolone resistance 57 cilengitide 57 aneuploid cells 57 boys Khoran Brown 57 hypothalamic pituitary adrenal axis 57 premenstrual dysphoric disorder PMDD 57 hyperammonemia 57 kanamycin 57 engineered RAP peptides 57 cyclin dependent kinase inhibitor 57 trophoblastic 57 Fibroblast 57 Prostate enlargement 57 WEALTH MINERALS LTD 57 Darapladib 57 peripherally acting 57 hormone receptor negative 57 protein secreted 57 XOMA 3AB biodefense 57 synovial tissue 57 DG# compounds targeting 57 Ectopia Cordis 57 TRAIL R1 57 INCB# [003] 57 Abscesses 57 Tumour Vascular Disrupting Agent 57 Sudhir Agrawal D.Phil 57 carcinoid 57 cytoprotective 57 p# MAPK 57 Radiofrequency ablation 57 SIX ROG VX 57 Meets Primary Endpoint 57 HIF 1α 57 PKC# 57 TLR7 agonist 57 telomerase reverse transcriptase 57 related apoptosis inducing 57 anticholinergic agents 57 delivers fluocinolone acetonide FA 57 Akt activation 57 basiliximab 57 hematological malignancy 57 transplanted bone marrow 57 sulindac 57 Soft Tissue Sarcoma 57 alpha interferon 57 rhIGF-I/rhIGFBP-3 57 inhalation powder 57 histological subtype 57 PTEN gene 57 immune modulatory 57 lenalidomide dexamethasone 57 Metastases 57 phosphate S1P 57 Genetic predisposition 57 naturally occurring neuroprotective 57 Crohns disease 57 multigene expression test 57 metastatic pancreatic 57 oral JAK1 57 lymphocytic 57 stage IIIb IV 57 Candidiasis 57 cytopenias 57 hormone refractory metastatic prostate 57 myotonic muscular dystrophy 57 topical retinoids 57 RQ PCR 57 Hematologic 57 Colon polyps 57 copper zinc superoxide 57 Soy isoflavones 57 Vaccine Adjuvant 57 coronary stent merged 57 Epstein Barr virus EBV 57 nonalcoholic steatohepatitis NASH 57 cytotoxic effects 57 Bacterial vaginosis 57 tricyclic antidepressant 57 mutated Ras 57 Hashimoto thyroiditis 57 progressive neurodegenerative disorder 57 Adjuvant Treatment 57 completely resected 57 invasive candidiasis 57 SGLT2 inhibitors 57 INVEGA ™ 57 FIRST HALF REPORT